Documente Academic
Documente Profesional
Documente Cultură
U n i t e d S It a
o s phiet as live
- a csq uMi raerdke
I nt f e c t i o n s
P r e veFo
n t re
i o nc aMsatr &
k eO
t O
p pppoorrttuunnii t i eess,, 22001200- 2 0 2 0
Pharma & Healthcare Consultants
Research Methodology
US Hospital-acquired Infections
Prevention Market Opportunities, 2020
Primary Research
Secondary Research
Government websites
Company annual reports, white
papers, investor presentations and
financial reports
market growth
2
2015E 2016F 2017F 2018F 2019F 2020F
Pharmaion
Research Methodology
Baseline Methodology:
For the study of the United States hospital-acquired infections prevention market, Pharmaion has gathered
information through an exhaustive search of credible databases prudently evaluated all the collected information
and presented it in the most accurate and detailed manner.
Primary Sources
Key Stakeholders:
Product/Brand Managers
Business Development
Managers
Qualitative and
quantitative data
from company
website, financial
reports, research
articles, designed
questionnaires
etc.
In-depth
interviews of key
stakeholders of
major companies
Regional Mangers
Regulatory Affairs Personnel
Marketing & Sales Managers
Head of Patient Support
Programme
Secondary Sources
Data
Triangulation
(Data
validation
through cross
verification
from primary
& secondary
sources)
3
Pharmaion
Research Methodology
United States Hospital-acquired Infections Prevention Market - Market Size Estimation
Calculation of United
States Sterilization for
Hospital-acquired
Infections Prevention
Market Size
Calculation
of Subsegment
market size
Calculation
of United
States
Disinfection
for Hospitalacquired
Infections
Prevention
Market Size
Bottom-up Approach
Top-down Approach
United States Hospital-acquired Infections Prevention market has been segmented into two categories:
Disinfection and Sterilization
Sterilization has been further categorized into three sub-segments: Equipment, Services, and
Consumables
Disinfection has been further classified into six sub segments: Disinfection Robots, Disinfectants,
Endoscope Reprocessors, Disinfectors, Wipes, and Personal-use Non-wovens.
4
Pharmaion
Ta b l e o f C o n t e n t s
S No.
Contents
1.
2.
Research Methodology
3.
Analyst View
4.
5.
5.2.
6.
By Prevention Type
5.2.2.
By Region
5.2.3.
By Company
6.2.
By Value
7.
By Value
By Type
7.2.
By Value
By Type
5
Pharmaion
Ta b l e o f C o n t e n t s
S No.
8.
9.
10.
Contents
Market Dynamics
8.1.
Drivers
8.2.
Challenges
9.2.
9.3.
9.4.
9.5.
10.2.
Guidelines
11.
12.
Competitive Landscape
12.1.
Competition Benchmarking
12.2.
Company Profiles
12.2.1.
Steris Corporation
12.2.2.
12.2.3.
12.2.4.
3M Company
12.2.5.
Belimed
12.2.6.
6
Pharmaion
Ta b l e o f C o n t e n t s
S No.
Contents
12.2.7.
12.2.8.
12.2.9.
12.2.10.
13.
Strategic Recommendations
14.
7
Pharmaion
Industry Brief
United States Hospital-acquired Infections Prevention Market to Grow at Over 7% Until 2020
Growing incidence of hospital-acquired infections and stringent government policies to drive the United States
hospital-acquired infections prevention market through 2020
According to recently published Pharmaion report,United States Hospital-acquired Infections Prevention Market
Opportunities, 2010 - 2020, hospital-acquired infections prevention market in the United States is projected to
grow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention market
can be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseases
among geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospitalacquired infections, under the Deficit Regulation Act, 2005,is also anticipated to drive demand for hospitalacquired infections prevention market in the United States during 2015 - 2020.
On the basis of prevention type, the market has been segmented into two categories, namely, sterilization and
disinfection. Among these categories, sterilization segment dominated the United States hospital-acquired
infections prevention market in 2014, and is anticipated to continue its dominance during forecast period on
account of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devices
used in diagnostic and treatment procedures. South region accounted for the largest share in the United States
hospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions.
With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupled
with growing adoption of gas plasma sterilization technology, the market for hospital-acquired infections
prevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover,
Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services
(HHS) developed the National Action Plan to Prevent Health Care-Associated Infections: Road Map to
Elimination in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings,
including acute care hospitals, ambulatory surgical centres, end-stage renal disease facilities and long-term care
facilities. said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global
pharmaceutical and healthcare consulting firm.
8
Pharmaion
Hospital-acquired Infections
Hospital-acquired infection, also known as nosocomial infection, is defined as an infection whose development
takes place in a favourable hospital environment, specifically those which are acquired by a patient during a
hospital visit and often develop among the hospital staff.
Hospital-acquired infections majorly leads to severe pneumonia and infections of bloodstream, urinary tract
and other parts of the body.
United States Hospital-acquired Infections Share, 2013
Abbreviations Used:
VAP, 20%
SSI, 20%
XXXX
XXXX
XXXX
CLABSI, 20%
CAUTI, 20%
XXXX
XXXX
HO-HCFA CDI,
20%
9
Pharmaion
Midwest Region
2011
2012
2013
2014
United States Costs of Commonly Hospital-acquired
West Region
1
2010
2011
2012
2013
2014
Catheterassociated
UTIs, 20.0%
C. Difficile
Infections,
20.0%
Central lineassociated
bloodstream
infection,
20.0%
Ventilatorassociated
Pneumonia, 20.0%
10
Surgical Site
Infections, 20.0%
31%
32%
16%
17%
14%
15%
5%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
2011
2012
2013
2014
5.9%
6%
31%
31.1%
Others
3M Company
ASP
Steris Corporation
10
Pharmaion
Report Ordering
Price
$2500
$3000
Enterprise License
$5000
11
Pharmaion
Related Reports
United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
Global Tissue Engineered Medical Devices Market Opportunities, 2020
Global Cervical Cancer Vaccine Market Opportunities, 2020
Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made
that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from
various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or
completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates
and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for clients
internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 360 1656
www.pharmaion.com
ASIA PACIFIC
Pharmaion Consultants Pvt. Ltd.
A 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com
12
Pharmaion